Regen BioPharma annual total debt
2016
2018
2022
2023
2024
2025
Regen BioPharma Total Debt Growth & History (RGBP)
Regen BioPharma's total debt was $1.0M for fiscal 2025.
View full Regen BioPharma company overviewRegen BioPharma annual total debt history
| Fiscal year | Period ended | Total debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $1.0M | $536,375 | +107.30% |
| 2024 | 2024-09-30 | $499,880 | −$255,324 | −33.81% |
| 2023 | 2023-09-30 | $755,204 | −$518,846 | −40.72% |
| 2022 | 2022-09-30 | $1.3M | — | — |
| 2018 | 2018-09-30 | $350,000 | — | — |
| 2016 | 2016-09-30 | $107,057 | — | — |
Regen BioPharma quarterly total debt
Q2.16
Q3.16
Q4.16
Q4.18
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Total debt | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $729,763 | −$306,481 | −29.58% |
| Q2 2026 | 2026-03-31 | $829,942 | −$137,690 | −14.23% |
| Q1 2026 | 2025-12-31 | $968,014 | — | — |
| Q4 2025 | 2025-09-30 | $1.0M | $536,375 | +107.30% |
| Q3 2025 | 2025-06-30 | $1.0M | — | — |
| Q2 2025 | 2025-03-31 | $967,632 | — | — |
| Q4 2024 | 2024-09-30 | $499,880 | — | — |
| Q4 2018 | 2018-09-30 | $350,000 | — | — |
| Q4 2016 | 2016-09-30 | $107,057 | — | — |
| Q3 2016 | 2016-06-30 | $102,703 | — | — |
| Q2 2016 | 2016-03-31 | $100,000 | — | — |
Regen BioPharma total debt trends
Between the periods ended 2016-09-30 and 2025-09-30, Regen BioPharma's total debt increased from $107,057 to $1.0M, a change of $929,198. The latest reported quarter, Q3 2026, shows $729,763.
About the metric
What total debt means
Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.
Calculation and source
SEC-reported and combined total debt
TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regen BioPharma source filings ↗